Tom Gibbs – Senior Investment Director, Debiopharm Innovation Fund Tom is a molecular microbiologist by training and has worked in the commercialization of life science technologies in start-ups and established companies in Europe and the USA for longer than he cares to admit. At Debiopharm Innovation Fund we invest in Europe, North America, and Israel at Seed and Series A in startups developing digital tools to transform drug development. Through these investments, he has gained extensive board-level experience.